Litcius/Paper detail

Evolution of delayed resistance to immunotherapy in a melanoma responder

David Liu, Jia‐Ren Lin, Emily Robitschek, Gyulnara G. Kasumova, Alex Heyde, Alvin Shi, Adam Kraya, Gao Zhang, Tabea Moll, Dennie T. Frederick, Yu‐An Chen, Shu Wang, Denis Schapiro, Li-Lun Ho, Kevin Bi, Avinash Sahu, Shaolin Mei, Benchun Miao, Tatyana Sharova, Christopher Alvarez‐Breckenridge, Jackson H. Stocking, Tommy Kim, Riley Fadden, Donald P. Lawrence, Mai P. Hoang, Daniel P. Cahill, Mohsen Malehmir, Martin A. Nowak, Priscilla K. Brastianos, Christine G. Lian, Eytan Ruppin, Benjamin Izar, Meenhard Herlyn, Eliezer M. Van Allen, Katherine L. Nathanson, Keith T. Flaherty, Ryan J. Sullivan, Manolis Kellis, Peter K. Sorger, Genevieve M. Boland

2021Nature Medicine134 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyMelanomaResistance (ecology)MedicineImmunologyBiologyCancer researchImmune systemEcologyImmunotherapy and Immune Responsesvaccines and immunoinformatics approachesT-cell and B-cell Immunology
Evolution of delayed resistance to immunotherapy in a melanoma responder | Litcius